Neuraxpharm, the Germany-based central nervous system specialist, has struck a deal that will see it market domestically a range of medical cannabis products made by Israel’s Panaxia Labs.
The collaboration will start in Germany – which Neuraxpharm said was “Europe’s largest cannabis market” – but was “expected to...





